Last month, the Congressional Research Service (CRS), Congress’s nonpartisan research arm, released two reports on 340B. The first report details the conflicting decisions from recent court cases related to 340B contract pharmacies and also give options on how Congress can intervene given the uncertainty with the program. The second report gives an overview of the 340B program as a whole, providing details on program data sales and entity participation, statutory requirements, changes to the 340B statute over time, Government Accountability Office reports and recommendations, and the contract pharmacy litigation. NACHC is actively working on a federal legislative strategy for 2023 to address the instability in the 340B Program. This week’s elections will determine who the key players are in Congress that health centers will need to work with to get 340B legislation passed.